Skip to main content
. 2022 Mar 24;11(7):1799. doi: 10.3390/jcm11071799
AZA azathioprine
GCs glucocorticoids
GCA giant cell arteritis
IL interleukin
IS immunosuppressant
IV intravenous
LEF leflunomide
MTX methotrexate
RCT randomised controlled trial
TCZ tocilizumab
TNF tumor necrosis factor